![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 14, 2018 1:32:25 AM
"Mr. Jang brings more than 25 years of experience in the mining industry and has extensive knowledge of Sarbanes-Oxley, internal controls, mergers and acquisitions, tax planning, and regulatory compliance matters."
"Mr. Jang has worked with Lundin Mining Corp., Augusta Resources Corp., Hudbay Minerals Inc. and Pan American Silver Corp. in various roles ranging from corporate controller to vice-president. He is a graduate of the British Columbia Institute of Technology's financial management program and holds a CPA, CMA designation."
2017-03-07 10:20 ET - News Release
Mr. Shawn Bromley reports
WINSTON RESOURCES INC. APPOINTS GORDON JANG AS CHAIRMAN OF ADVISORY BOARD
Winston Resources Inc., in conjunction with its proposed acquisition of Green Tree Therapeutics, has appointed Gordon Jang as chairman of the company's advisory board. The advisory board will enhance the company's ability to bring in tactical growth partnerships through strategic investments, which are an important part of the company's approach to capture sales and the newest developing technologies in the cannabinoid sector.
Mr. Jang brings more than 25 years of experience in the mining industry and has extensive knowledge of Sarbanes-Oxley, internal controls, mergers and acquisitions, tax planning, and regulatory compliance matters.
Mr. Jang has worked with Lundin Mining Corp., Augusta Resources Corp., Hudbay Minerals Inc. and Pan American Silver Corp. in various roles ranging from corporate controller to vice-president. He is a graduate of the British Columbia Institute of Technology's financial management program and holds a CPA, CMA designation.
Mr. Jang brings invaluable experience, expertise and insight, and the company looks forward to developing numerous growth strategies. Mr. Jang will be granted options at a later date, subject to approval by the Canadian Securities Exchange.
Update on proposed transaction
On Feb. 24, 2017, Winston signed a letter of intent with GT Therapeutics Corp., doing business as Green Tree Therapeutics, an arm's-length private British Columbia company, pursuant to which the company will complete a reverse takeover and acquire from Green Tree Therapeutics' shareholders 100 per cent of the shares of Green Tree Therapeutics, causing Green Tree Therapeutics to become a wholly owned subsidiary of Winston. On completion of the transaction, the business of Green Tree Therapeutics will become the business of Winston, and the company will abandon the Pigeon River property.
The company continues to work through due diligence and negotiation of the definitive agreement. The transaction remains subject to certain closing conditions, including completion of due diligence, the negotiation and signing of a definitive agreement, and obtaining all necessary approvals, including approval of the respective boards, the approval of the Canadian Securities Exchange, and if applicable, shareholders of the company. There can be no guarantees that the transaction will be completed as proposed or at all.
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM